Literature DB >> 23184150

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.

Marc Henrion1, Matthew Frampton, Ghislaine Scelo, Mark Purdue, Yuanqing Ye, Peter Broderick, Alastair Ritchie, Richard Kaplan, Angela Meade, James McKay, Mattias Johansson, Mark Lathrop, James Larkin, Nathaniel Rothman, Zhaoming Wang, Wong-Ho Chow, Victoria L Stevens, W Ryan Diver, Susan M Gapstur, Demetrius Albanes, Jarmo Virtamo, Xifeng Wu, Paul Brennan, Stephen Chanock, Timothy Eisen, Richard S Houlston.   

Abstract

Genome-wide association studies (GWASs) of renal cell cancer (RCC) have identified four susceptibility loci thus far. To identify an additional RCC common susceptibility locus, we conducted a GWAS and performed a meta-analysis with published GWASs (totalling 2215 cases and 8566 controls of European background) and followed up the most significant association signals [nine single nucleotide polymorphisms (SNPs) in eight genomic regions] in 3739 cases and 8786 controls. A combined analysis identified a novel susceptibility locus mapping to 2q22.3 marked by rs12105918 (P = 1.80 × 10(-8); odds ratio 1.29, 95% CI: 1.18-1.41). The signal localizes to intron 2 of the ZEB2 gene (zinc finger E box-binding homeobox 2). Our findings suggest that genetic variation in ZEB2 influences the risk of RCC. This finding provides further insights into the genetic and biological basis of inherited genetic susceptibility to RCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184150      PMCID: PMC3554205          DOI: 10.1093/hmg/dds489

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

Review 1.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

2.  The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.

Authors:  Summer S Han; Meredith Yeager; Lee E Moore; Ming-Hui Wei; Ruth Pfeiffer; Ousmane Toure; Mark P Purdue; Mattias Johansson; Ghislaine Scelo; Charles C Chung; Valerie Gaborieau; David Zaridze; Kendra Schwartz; Neonilia Szeszenia-Dabrowska; Faith Davis; Vladimir Bencko; Joanne S Colt; Vladimir Janout; Vsevolod Matveev; Lenka Foretova; Dana Mates; M Navratilova; Paolo Boffetta; Christine D Berg; Robert L Grubb; Victoria L Stevens; Michael J Thun; W Ryan Diver; Susan M Gapstur; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Laurie Burdett; Antonin Brisuda; James D McKay; Joseph F Fraumeni; Nilanjan Chatterjee; Philip S Rosenberg; Nathaniel Rothman; Paul Brennan; Wong-Ho Chow; Margaret A Tucker; Stephen J Chanock; Jorge R Toro
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

Review 3.  Genetics of coeliac disease.

Authors:  R S Houlston; D Ford
Journal:  QJM       Date:  1996-10

Review 4.  Hereditary kidney cancer: unique opportunity for disease-based therapy.

Authors:  W Marston Linehan; Peter A Pinto; Gennady Bratslavsky; Elizabeth Pfaffenroth; Maria Merino; Cathy D Vocke; Jorge R Toro; Donald Bottaro; Len Neckers; Laura S Schmidt; Ramaprasad Srinivasan
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

5.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.

Authors:  D E Goldgar; D F Easton; L A Cannon-Albright; M H Skolnick
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

6.  Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.

Authors:  Peter Broderick; Yufei Wang; Jayaram Vijayakrishnan; Athena Matakidou; Margaret R Spitz; Timothy Eisen; Christopher I Amos; Richard S Houlston
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

7.  Common regulatory variation impacts gene expression in a cell type-dependent manner.

Authors:  Antigone S Dimas; Samuel Deutsch; Barbara E Stranger; Stephen B Montgomery; Christelle Borel; Homa Attar-Cohen; Catherine Ingle; Claude Beazley; Maria Gutierrez Arcelus; Magdalena Sekowska; Marilyne Gagnebin; James Nisbett; Panos Deloukas; Emmanouil T Dermitzakis; Stylianos E Antonarakis
Journal:  Science       Date:  2009-07-30       Impact factor: 47.728

8.  A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.

Authors:  Xifeng Wu; Ghislaine Scelo; Mark P Purdue; Nathaniel Rothman; Mattias Johansson; Yuanqing Ye; Zhaoming Wang; Diana Zelenika; Lee E Moore; Christopher G Wood; Egor Prokhortchouk; Valerie Gaborieau; Kevin B Jacobs; Wong-Ho Chow; Jorge R Toro; David Zaridze; Jie Lin; Jan Lubinski; Joanna Trubicka; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Viorel Jinga; Vladimir Bencko; Alena Slamova; Ivana Holcatova; Marie Navratilova; Vladimir Janout; Paolo Boffetta; Joanne S Colt; Faith G Davis; Kendra L Schwartz; Rosamonde E Banks; Peter J Selby; Patricia Harnden; Christine D Berg; Ann W Hsing; Robert L Grubb; Heiner Boeing; Paolo Vineis; Françoise Clavel-Chapelon; Domenico Palli; Rosario Tumino; Vittorio Krogh; Salvatore Panico; Eric J Duell; José Ramón Quirós; Maria-José Sanchez; Carmen Navarro; Eva Ardanaz; Miren Dorronsoro; Kay-Tee Khaw; Naomi E Allen; H Bas Bueno-de-Mesquita; Petra H M Peeters; Dimitrios Trichopoulos; Jakob Linseisen; Börje Ljungberg; Kim Overvad; Anne Tjønneland; Isabelle Romieu; Elio Riboli; Victoria L Stevens; Michael J Thun; W Ryan Diver; Susan M Gapstur; Paul D Pharoah; Douglas F Easton; Demetrius Albanes; Jarmo Virtamo; Lars Vatten; Kristian Hveem; Tony Fletcher; Kvetoslava Koppova; Olivier Cussenot; Geraldine Cancel-Tassin; Simone Benhamou; Michelle A Hildebrandt; Xia Pu; Mario Foglio; Doris Lechner; Amy Hutchinson; Meredith Yeager; Joseph F Fraumeni; Mark Lathrop; Konstantin G Skryabin; James D McKay; Jian Gu; Paul Brennan; Stephen J Chanock
Journal:  Hum Mol Genet       Date:  2011-10-18       Impact factor: 6.150

9.  Patterns of cis regulatory variation in diverse human populations.

Authors:  Barbara E Stranger; Stephen B Montgomery; Antigone S Dimas; Leopold Parts; Oliver Stegle; Catherine E Ingle; Magda Sekowska; George Davey Smith; David Evans; Maria Gutierrez-Arcelus; Alkes Price; Towfique Raj; James Nisbett; Alexandra C Nica; Claude Beazley; Richard Durbin; Panos Deloukas; Emmanouil T Dermitzakis
Journal:  PLoS Genet       Date:  2012-04-19       Impact factor: 5.917

10.  Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.

Authors:  Peter Broderick; Daniel Chubb; David C Johnson; Niels Weinhold; Asta Försti; Amy Lloyd; Bianca Olver; Yussanne Ma; Sara E Dobbins; Brian A Walker; Faith E Davies; Walter A Gregory; J Anthony Childs; Fiona M Ross; Graham H Jackson; Kai Neben; Anna Jauch; Per Hoffmann; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Ian P Tomlinson; Hartmut Goldschmidt; Kari Hemminki; Gareth J Morgan; Richard S Houlston
Journal:  Nat Genet       Date:  2011-11-27       Impact factor: 38.330

View more
  31 in total

1.  Testing for Ancient Selection Using Cross-population Allele Frequency Differentiation.

Authors:  Fernando Racimo
Journal:  Genetics       Date:  2015-11-23       Impact factor: 4.562

Review 2.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

3.  Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer.

Authors:  Moubin Lin; Liren Zhang; Michelle A T Hildebrandt; Maosheng Huang; Xifeng Wu; Yuanqing Ye
Journal:  Oncotarget       Date:  2017-08-24

4.  International cancer seminars: a focus on kidney cancer.

Authors:  G Scelo; J N Hofmann; R E Banks; P Bigot; R S Bhatt; G Cancel-Tassin; S K Chew; C J Creighton; O Cussenot; I J Davis; B Escudier; T M Frayling; C Häggström; M A T Hildebrandt; I Holcatova; M Johansson; W M Linehan; D F McDermott; K L Nathanson; S Ogawa; E J Perlman; M P Purdue; P Stattin; C Swanton; N S Vasudev; X Wu; A Znaor; P Brennan; S J Chanock
Journal:  Ann Oncol       Date:  2016-04-29       Impact factor: 32.976

5.  Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes.

Authors:  Xiang Shu; Mark P Purdue; Yuanqing Ye; Huakang Tu; Christopher G Wood; Nizar M Tannir; Zhaoming Wang; Demetrius Albanes; Susan M Gapstur; Victoria L Stevens; Nathaniel Rothman; Stephen J Chanock; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-16       Impact factor: 4.254

Review 6.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 7.  Tumour and patient factors in renal cell carcinoma-towards personalized therapy.

Authors:  Ahmed Q Haddad; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2015-04-14       Impact factor: 14.432

Review 8.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

9.  Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites.

Authors:  Stephanie C Melkonian; Carrie R Daniel; Michelle A T Hildebrandt; Nizar M Tannir; Yuanqing Ye; Wong-Ho Chow; Christopher G Wood; Xifeng Wu
Journal:  Am J Epidemiol       Date:  2014-07-22       Impact factor: 4.897

10.  Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.

Authors:  Xiang Shu; Jianchun Gu; Maosheng Huang; Nizar M Tannir; Surena F Matin; Jose A Karam; Christopher G Wood; Xifeng Wu; Yuanqing Ye
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.